TABLE 1.
Patient demographics
| Fosmetpantotenate (n = 41) | Placebo (n = 43) | |
|---|---|---|
| Age, years, mean (SD) | ||
|
minimum maximum |
22.6 (10.6) 6, 58 |
23.1 (13.6) 6, 58 |
| Age group, n (%) | ||
| Pediatric | 14 (34.1) | 16 (37.2) |
| Adult | 27 (65.9) | 27 (62.8) |
| Sex, n (%) | ||
| Male | 21 (51.2) | 24 (55.8) |
| Female | 20 (48.8) | 19 (44.2) |
| Ethnicity a | ||
| Hispanic or Latino | 8 (19.5) | 2 (4.7) |
| Not Hispanic or Latino | 28 (68.3) | 36 (83.7) |
| Not reported | 5 (12.2) | 5 (11.6) |
| Racea | ||
| American Indian or Alaska Native | 0 | 0 |
| Asian | 1 (2.4) | 2 (4.7) |
| Black or African American | 0 | 4 (9.3) |
| Native Hawaiian or Other Pacific Islander | 0 | 0 |
| White | 25 (61.0) | 28 (65.1) |
| Multiple | 2 (4.9) | 0 |
| Other | 4 (9.8) | 3 (7.0) |
| Unknown | 6 (14.6) | 6 (14.0) |
| Missing | 3 (7.3) | 0 |
| Weight, kg, mean (SD) | 49.2 (18.9) | 49.0 (20.6) |
| Pediatric (n = 14 and 16) | 31.6 (13.0) | 30.8 (11.9) |
| Adult (n = 27 and 27) | 58.3 (14.5) | 59.7 (16.7) |
| BMI, kg/m2, mean (SD) b | 19.1 (4.0) | 19.6 (4.6) |
a
Race and ethnicity data were not available for up to 14.6% of patients, including country‐specific limitation on collection of these data within clinical trials.
b
Data are not available for one patient receiving fosmetpantotenate and two patients receiving placebo.
Abbreviations: SD, standard deviation; BMI, body mass index.